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Introduction
Angiogenesis is the growth of new blood vessels from preexisting 
vessels and occurs through a tightly regulated response of 
endothelial cells (ECs) to proangiogenic factors (1, 2). Insufficient 
vascular supply, which may arise due to impaired vessel growth 
(3), capillary loss (4), or vessel obstruction (5), causes tissue 
ischemia. While increased angiogenesis correlates with better 
outcomes in ischemic diseases like stroke (6), ischemia and 
the upregulation of VEGFA can drive aberrant angiogenesis, 
exacerbating certain diseases. This is particularly evident in 
retinal diseases, such as proliferative diabetic retinopathy, retinal 
vein occlusion, and retinopathy of prematurity, in which aberrant 
angiogenesis (neovascularization) increases the risk of severe 
vision loss and blindness (7). Current treatments for neovascular 
disease in the retina revolve around reducing the angiogenic 
stimulus either by decreasing the metabolic activity of the retina 
or by direct inhibition of VEGFA (8–12). While these approaches 
improve visual outcomes, many patients show either no response 
or a suboptimal response (8, 9). Capillary regression and the loss 
of ECs from the microvasculature is commonly associated with 
progression to neovascular disease in the retina and can occur 
in response to metabolic dysregulation (4), hyperoxia (13), or 
interrupted blood flow (14, 15). ECs die by apoptosis, a genetically 
programmed form of cell death (16), in settings where extensive 
vessel regression occurs (17, 18). Retinal capillaries in patients 
with diabetic retinopathy, for example, show elevated levels of 
EC apoptosis before progression to the proliferative phase (4, 
19). Understanding the role of apoptosis in EC loss and vessel 
regression leading to retinal ischemia may therefore provide 
new insight into vascular changes associated with ischemia and 
potentially new avenues for preventing disease progression.
Apoptosis is regulated by 2 pathways, one consisting of 
BCL2 family proteins, the other consisting of cell surface “death 
receptors.” Previous studies have demonstrated a key role for the 
BCL2 family of proteins in the regulation of EC apoptosis (17). 
The BCL2 family consists of opposing factions of prosurvival and 
proapoptotic members (16), the balance of which determines 
whether the apoptosis effector proteins BAK and BAX become 
activated (20). Previous studies have shown that among the BCL2 
family, the prosurvival protein MCL1 (21), the proapoptotic protein 
BIM (22, 23), and the 2 effector proteins BAK and BAX (24) have a 
central role in regulating EC apoptosis in the retina in vivo.
Vessel regression is a normal process necessary for establishing 
hierarchic vessel patterning during angiogenesis and the removal 
of redundant or damaged vascular networks (17, 18). During 
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was developed as a model of retinopathy of prematurity. To block 
apoptosis, we used mice that we previously generated, in which 
apoptosis was inactivated in ECs through combined deletion 
of BAK and BAX (Bak–/– BaxEC/EC mice [ref. 24]). Bak–/– BaxEC/EC 
mice lack BAK in all tissues and BAX only in ECs, a necessary 
strategy because Bak–/– mice are viable, whereas most Bak–/– Bax–/– 
double-null mice die at birth due to a range of birth defects 
(30). Relevant to the age of mice studied here, Bak–/– BaxEC/EC 
mice develop a normal retinal vascular network in the first few 
weeks after birth (24). After 24 hours of exposure to high oxygen, 
control-genotype mice contained extensive numbers of apoptotic 
ECs (active caspase-3+ PECAM1+ cells). In contrast, retinas from 
Bak–/– BaxEC/EC mice were almost completely devoid of apoptotic 
ECs after 24 or 48 hours of oxygen exposure (Figure 1, A and B). 
By contrast, other forms of programmed cell death, namely death 
receptor–mediated apoptosis (caspase-8–dependent) and MLKL-
dependent necroptosis, were dispensable for vaso-obliteration, as 
caspase-8–/– Mlkl–/– double-knockout mice underwent normal vaso-
obliteration when exposed to high oxygen (Supplemental Figure 
1, B and C). These results confirm the central role of the BCL2-
regulated apoptosis pathway in the apoptotic response of ECs in 
the OIR model.
As a result of blocking apoptosis, Bak–/– BaxEC/EC retinas 
contained significantly more vasculature than retinas of control 
littermates following 24–48 hours of high oxygen exposure (Figure 
1C and Supplemental Figure 1D). Despite this, the vessel area in 
Bak–/– BaxEC/EC retinas declined with increasing duration of high 
oxygen exposure (Figure 1D). This loss of vasculature was due to 
vessel regression based on the reduced occupancy of collagen IV+ 
vascular basement membranes with PECAM1+ ECs (ref. 31; Figure 
1, E and F; and Supplemental Figure 1E). By 48 hours of exposure to 
high oxygen, ongoing vessel regression had caused the network in 
Bak–/– BaxEC/EC retinas to degenerate into isolated vessel fragments 
and endothelial clusters that in many cases remained linked by 
empty collagen IV sleeves (Figure 1, E and G), evidence that they 
were once part of an interconnected vascular network.
The Tie2-Cre transgene used to generate Bak–/– BaxEC/EC mice 
is active in hematopoietic cells as well as ECs. The Cdh5-CreERT2 
transgene (32) is active in ECs but not hematopoietic cells 
following postnatal administration of tamoxifen (21). Postnatal 
deletion of Bax only from ECs using this Cre (Bak–/– BaxiEC/iEC 
mice) recapitulated the fragmented vascular phenotype after 48 
hours of high oxygen exposure (Supplemental Figure 1, F–H). This 
result confirmed that the fragmented vascular phenotype is due 
to apoptosis blockade specifically in ECs. Therefore, blocking 
apoptosis in ECs does not prevent vessel regression triggered by 
exposure to high oxygen.
EC apoptosis–independent loss of blood flow precedes vessel 
regression. We sought to determine why apoptosis suppression 
could not prevent the loss of retinal capillary network integrity 
following high oxygen exposure by investigating the causes of EC 
apoptosis and vessel regression. VEGFA promotes EC survival via 
the BCL2 pathway (33, 34). It is downregulated during exposure 
to high oxygen, and this has been suggested to contribute to 
vessel regression in the OIR model (35–37). VEGFR2 is the major 
VEGFA receptor responsible for survival signaling by VEGFA (38). 
Using tamoxifen-inducible, EC-specific Vegfr2 mutants described 
angiogenic vessel remodeling, local differences in blood flow 
shear between neighboring vessel segments determine which will 
be “pruned” away (25–27). This selective vessel pruning is driven 
by EC migration (25, 27, 28), does not cause ischemia, and does 
not require EC apoptosis (24). In contrast, apoptosis does appear 
responsible for capillary regression in other contexts, including 
those that leave tissues with insufficient vascular supply, causing 
ischemia. Exactly how apoptosis contributes to vessel loss in this 
context and the outcomes of preventing it are not well understood.
Here we have investigated the effect of blocking EC apoptosis 
in a mouse model of ischemia-induced neovascular disease (4), 
in which blocking apoptosis is known to prevent capillary loss 
and subsequent neovascularization (23). Our results show that 
EC apoptosis in this model is secondary to a vessel closure event 
that deprives downstream capillaries of blood flow. Rather than 
preventing this vessel closure or subsequent vessel degeneration, 
protecting ECs from apoptosis instead preserved ECs from these 
closed vessels within the ischemic region that were capable of 
rebuilding a functional vascular network in response to hypoxia-
derived signals, restoring tissue oxygenation and mitigating the 
damaging effects of prolonged hypoxia on the retina.
Results
Blocking BCL2 pathway apoptosis results in EC survival and 
delayed vessel regression. To determine whether EC apoptosis was 
responsible for vessel regression causing ischemia, we investigated 
its role in the oxygen-induced retinopathy (OIR) model (ref. 29 
and Supplemental Figure 1A; supplemental material available 
online with this article; https://doi.org/10.1172/JCI127668DS1). 
In this model, transient exposure of mice to high oxygen causes 
the apoptotic death of ECs and consequent regression of retinal 
capillaries in the center of the retina, resulting in relative retinal 
hypoxia once the mice are returned to room air oxygen levels. 
This is followed by the development of abnormal vascular lesions 
that resemble those found in neovascular retinal diseases (4) and 
Figure 1. Blocking apoptosis prevents loss of ECs from retinas exposed 
to high oxygen. (A and B) Representative images and quantification of 
EC apoptosis visualized by active caspase-3 staining (cyan) and PECAM1 
(red) in control (n = 8) and Bak–/– BaxEC/EC (24 hours, n = 3; 48 hours, n = 5) 
retinas after 24 or 48 hours in high oxygen. Quantitative data from control 
mice exposed to high oxygen for 48 hours are not shown because there are 
no central retina capillaries remaining. Arrow indicates rare apoptotic EC 
in Bak–/– BaxEC/EC retina. Scale bars: 100 μm. Student’s 2-tailed t test. (C) 
PECAM1 staining of control and Bak–/– BaxEC/EC retinas after 48 hours in high 
oxygen. Scale bars: 500 μm. (D) Quantification of central retina vessel area  
in mice exposed to high oxygen for 24 hours (control, n = 4; Bak–/– BaxEC/EC,  
n = 5) or 48 hours (control, n = 6; Bak–/– BaxEC/EC, n = 6) compared with 8-day-
old normoxic mice (control, n = 3; Bak–/– BaxEC/EC, n = 3). Multiple t tests using 
Holm-Šidák correction for multiple comparisons. (E) PECAM1 (cyan) and col-
lagen IV (red) staining within the central retina of control and Bak–/– BaxEC/EC 
mice raised in room air (normoxia) or for 48 hours in high oxygen. Scale bars: 
80 μm. (F and G) Quantification of vessel regression and network fragmen-
tation in the central retina of Bak–/– BaxEC/EC mice exposed to high oxygen for 
24 hours (n = 5) or 48 hours (n = 6) compared with 8-day-old normoxic mice 
(control, n = 3; Bak–/– BaxEC/EC, n = 3). Quantitative data from control mice 
exposed to high oxygen are not shown because there are no central retina 
capillaries remaining. One-way ANOVA with Tukey’s multiple-comparisons 
test. All data are mean ± SEM. Each circle represents 1 animal.
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increase in vessel area accompanied by the cessation of vessel 
regression and reestablishment of an interconnected vascular 
network (Figure 3, A and C–F).
To understand how an intact vascular network was 
reestablished in the Bak–/– BaxEC/EC mice, we performed time-
lapse imaging to track the fate of the preserved ECs. For this, 
the Cre-inducible, cell membrane–targeted EGFP reporter 
allele mTmG (46) was intercrossed with the tamoxifen-inducible 
Bak–/– BaxiEC/iEC mice. Following tamoxifen administration, Bak–/– 
BaxiEC/iEC mTmGki/+ pups were exposed to high oxygen for 48 
hours, returned to room air for 12 hours to initiate the hypoxic 
response, and then retinas were explanted and immediately time-
lapse-imaged at 30-minute intervals for 5 hours (Supplemental 
Figure 3, B and C). Time-lapse imaging showed that ECs in the 
isolated clusters adopted a migratory phenotype consistent with 
tip cell activity normally seen during sprouting angiogenesis (1). 
Through this, the isolated ECs actively reestablished connections 
with their neighbors, reassembling the network (Figure 3G 
and Supplemental Videos 1–3, black arrows). Vessel sprouts 
establishing new connections were also observed from already 
intact vessels (Supplemental Videos 1 and 2, red arrows). In many 
cases, migrating ECs extended multiple filopodial projections 
suggesting de novo pathfinding similar to the sprouting 
angiogenesis seen in control mice (Figure 3H, Supplemental 
Video 3, red arrows). In other cases, ECs appeared to track along 
predetermined paths (Supplemental Video 3, blue arrows). These 
data show that isolated EC clusters protected from apoptosis are 
active participants in the reestablishment of an intact vascular 
network during revascularization of the ischemic retina.
During normal sprouting angiogenesis in the retina, new-
vessel growth is coupled to EC proliferation (47). Control and 
Bak–/– BaxEC/EC retinas were stained for phospho–histone H3 
(Ser10) to identify proliferating ECs 24 hours after return to 
room air. In control retinas, EC proliferation accompanied 
regrowth of the central retinal vasculature (Figure 4, A and B, and 
Supplemental Figure 3D). In contrast, reassembling vessels in the 
center of Bak–/– BaxEC/EC retinas contained few proliferating ECs 
(Figure 4, A and B). EC proliferation in the peripheral vasculature 
was similar between control and Bak–/– BaxEC/EC mice, indicating 
that there was not a general EC proliferation defect in the mutants 
(Supplemental Figure 3E).
To determine whether EC number changed during the 
process of regression and reassembly, we quantified EC number 
in normal (normoxic), fragmented (48 hours high oxygen), and 
reassembled (48 + 24 RA) Bak–/– BaxEC/EC central retina vessels, 
using EC nuclei markers FLI1 and ERG. FLI1 was downregulated 
in ECs of fragmented vessels (Supplemental Figure 3F); therefore 
ERG was used to quantify EC number under this condition. 
We found that the number of ECs in the central retina of Bak–/– 
BaxEC/EC mice remained constant between normoxic, fragmented, 
and reassembled vessels (Figure 4, C and D). Collectively, these 
data show that blocking apoptosis prevents the loss of ECs from the 
retina and that reassembly of these cells back into interconnected 
vessels does not require the production of new ECs.
The extent of network fragmentation influences vessel reassem-
bly. The degree of network fragmentation in Bak–/– BaxEC/EC mice 
was proportional to the time spent in the high-oxygen environ-
previously (39), we found that reducing VEGFR2 through 
tamoxifen administration from postnatal day 7 (P7; the age at 
which retinal vessels are susceptible to high oxygen) did not result 
in widespread loss of central retina capillaries when analyzed at 
P10 (Supplemental Figure 2, A and B). This result suggests that a 
reduction in VEGFA activity alone is not sufficient to replicate the 
vaso-obliteration that occurs in the OIR model and is consistent 
with previous findings (40, 41).
Reduced blood flow triggers the regression of immature 
retinal vessels (28, 41), and EC apoptosis in OIR has previously 
been proposed to occur secondary to loss of blood flow (41, 42). 
Widespread EC apoptosis was evident in control mice but not 
Bak–/– BaxEC/EC mice 8 hours after onset of exposure to high oxygen 
(Supplemental Figure 2, C and D). With few exceptions, apoptosis 
was localized to nonperfused vessels based on costaining for active 
caspase-3 and intravenously perfused Lycopersicon esculentum 
lectin (Supplemental Figure 2E), which binds to and marks ECs 
in patent vessels. Loss of flow was mostly observed downstream 
of arterial side branches that had closed (Figure 2A). This pattern 
of vessel closure was observed in both control and Bak–/– BaxEC/EC 
mice (Figure 2A). The number of perfused arterial side branches 
remaining at 8 hours was not different between Bak–/– BaxEC/EC 
mice and controls (Figure 2, A and B). This demonstrates that 
apoptosis is not responsible for hyperoxia-induced arterial side-
branch closure or deprivation of downstream capillaries of blood 
flow. Nonetheless, the regression of closed arterial side branches 
was delayed in the absence of apoptosis, as fewer nonperfused side 
branches in the Bak–/– BaxEC/EC mice had fully disconnected their 
lumens from the artery by 8 hours (Supplemental Figure 2, F and 
G). There was also less regression occurring in nonperfused Bak–/– 
BaxEC/EC capillaries relative to controls (Figure 2, C and D), although 
the nonperfused capillaries in mutants still showed slightly elevated 
levels of regression relative to the peripheral capillary plexus region 
that is unaffected by high oxygen exposure (Figure 2D).
Retinas vaso-obliterated by exposure to high oxygen become 
hypoxic on return to room air owing to the loss of the central capillary 
network (43), and this was observed in control mice following either 
24 or 48 hours of exposure to high oxygen (Figure 2, E and F). The 
extent of hypoxia in littermate Bak–/– BaxEC/EC retinas was equivalent 
to that in the controls, consistent with loss of blood flow to and 
fragmentation of the central retinal capillaries (Figure 2, E and F). 
These data suggest that vessel regression still occurs in the absence 
of apoptosis, likely as a result of blood flow loss.
Preserved Bak–/– BaxEC/EC ECs rapidly reassemble the vessel network 
in response to hypoxia. In WT mice, the onset of hypoxia following 
return to room air induces a sprouting angiogenic response from 
the remaining vasculature that gradually revascularizes the 
central retina through centripetal growth of the network (44, 45). 
To determine whether the preserved ECs in the central retina of 
Bak–/– BaxEC/EC mice could also respond to hypoxia, mice were 
exposed to high oxygen for 48 hours to fragment the vascular 
network, returned to room air to induce hypoxia in the avascular 
retina, then examined 24 hours later (referred to as 48 + 24 RA) 
(Supplemental Figure 3A). As expected, new-vessel growth from 
the peripheral plexus and radial veins in control mice only partially 
revascularized the retina 24 hours after onset of hypoxia (Figure 
3, A–C). In contrast, Bak–/– BaxEC/EC retinas showed a significant 
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Figure 2. Blocking apoptosis delays, but does not prevent, vessel regression. (A) Collagen IV and perfused lectin staining in control and Bak–/– BaxEC/EC 
central retinas. Yellow arrows indicate arterial side-branch closure; pink arrowheads indicate representative downstream vessel closure points. Scale bars: 
100 μm. (B) Perfused arterial side branches in control (n = 6) and Bak–/– BaxEC/EC mice (n = 5). Student’s 2-tailed t test. (C) Representative regions of nonper-
fused capillaries from the central retinas of control and Bak–/– BaxEC/EC mice stained for collagen IV (red), ICAM2 (cyan), and perfused lectin (green). Scale 
bars: 50 μm. (D) Vessel regression in the peripheral and central retina capillaries from control (n = 4) and Bak–/– BaxEC/EC (n = 3) mice. Two-way ANOVA using 
Tukey’s multiple-comparisons test. (E) Hypoxia visualized by pimonidazole (red) staining and ECs by PECAM1 (cyan) in control and Bak–/– BaxEC/EC retinas 
following 48 hours of high oxygen exposure. Scale bars: 500 μm. (F) Central retina hypoxic area in mice exposed to high oxygen for 24 hours (control, n = 
4; Bak–/– BaxEC/EC, n = 3) or 48 hours (control, n = 6; Bak–/– BaxEC/EC, n = 5). Multiple t tests using Holm-Šidák correction for multiple comparisons. Animals in 
A–D were exposed to high oxygen for 8 hours. All data are mean ± SEM. Each circle represents 1 animal.
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ment. Those mice exposed to high oxygen for 24 hours showed 
less extensive vessel regression and network fragmentation than 
those exposed for 48 hours (Figure 1, F and G, and Supplemental 
Figure 4A). When mice exposed to high oxygen for 24 hours were 
returned to room air for a further 24 hours to stimulate hypoxia- 
driven vessel reassembly (24 + 24 RA), the vascular area, vessel 
width, and network branch points were all closer to those of mice 
raised in normoxia than was observed in the Bak–/– BaxEC/EC mice 
exposed to 48 + 24 RA (Supplemental Figure 4, B–D). This finding 
suggests that the sooner tissue hypoxia manifests after flow inter-
ruption, the more efficiently apoptosis-resistant ECs can reassem-
ble a functional vascular network.
Vessel reassembly facilitated by the blocking of apoptosis reverses 
retinal hypoxia, and associated pathological responses. To assess 
whether reassembled vessels were functional, we investigated 
vessel perfusion and retinal hypoxia in Bak–/– BaxEC/EC and control 
mice subjected to 48 + 24 RA. Lectin perfusion showed that most 
reassembled vessels in Bak–/– BaxEC/EC retinas were patent and 
perfused 24 hours after return to room air (Figure 5A). Consistent 
with this, there was significantly less hypoxia in the central retinas 
of Bak–/– BaxEC/EC mice compared with similarly treated controls 
(Figure 5, B and C). These mice also displayed less retinal hypoxia 
than Bak–/– BaxEC/EC retinas still in the fragmented state immediately 
following exposure to 48 hours of high oxygen alone (Figure 5, B 
and C). Retinal hypoxia in the OIR model following return to room 
air results in increased expression of VEGFA (36, 48). Accordingly, 
VEGFA protein levels increased substantially in control mice 24 
hours after return to room air, but this was significantly reduced 
in Bak–/– BaxEC/EC retinas (Figure 5D). This was consistent with 
there being less hypoxia as a result of reassembly of the vascular 
network and restoration of the vascular supply. As neovascular 
lesion formation is dependent on VEGFA (44, 45, 49), we assessed 
whether the reduction in hypoxia-induced VEGFA brought 
about by vessel reassembly would also translate to a reduction 
in neovascular lesion formation. Neovascular lesions have a 
glomerular vessel structure, distinct from the normal branched 
vessel network pattern. These lesions stained brightly for the 
basement membrane protein collagen IV (Figure 5G). The strong 
contrast in collagen IV signals between normal and neovascular 
vessels enabled us to quantify neovascular lesions as bright, 
globular collagen IV structures. Whereas control mice exposed 
to high oxygen and returned to room air for 5 days developed 
extensive neovascular lesion area, this was significantly reduced 
in Bak–/– BaxEC/EC retinas (Figure 5, E–H). Additionally, Müller cell 
gliosis, an indicator of retinal stress, was significantly reduced in 
Bak–/– BaxEC/EC mice compared with the controls (Figure 5, I and J). 
These findings demonstrate that reassembled vessel networks are 
functional and prevent pathological consequences of prolonged 
tissue hypoxia in the retina.
Reducing VEGFA levels does not prevent vessel reassembly or its 
suppression of neovascular lesion formation. As elevated VEGFA 
drives aberrant angiogenesis in ischemic retinas, we investigated 
whether it was also necessary for the vessel reassembly that 
occurred in the absence of EC apoptosis. To test this, Bak–/– 
BaxEC/EC mice were exposed to 48 + 24 RA to induce network 
fragmentation and reassembly and were treated with either a 
VEGFA-neutralizing antibody (50) or isotype control on return 
to room air (Figure 6A). VEGFA neutralization did not appear 
to prevent vessel reassembly, as no difference was observed in 
central retinal vascular area between mice treated with anti-
VEGFA and those treated with isotype control antibody (Figure 6, 
B and C). Supporting this, the hypoxic area in the central retina 
was not different in Bak–/– BaxEC/EC mice treated with anti-VEGFA 
versus isotype control antibody (Figure 6D). We confirmed that 
the systemically delivered antibodies were neutralizing VEGFA in 
the retinal vessels by staining for ESM1 (Supplemental Figure 5, 
A–C). The expression of ESM1 is dependent on VEGFA (51). Vessel 
reassembly proceeded in anti-VEGFA–treated mice even under 
conditions of high VEGFA signaling inhibition, in which ESM1 
expression was reduced by 94% (Supplemental Figure 5, A–E). 
VEGFA inhibition under conditions that reduced neovascular 
lesion area by 50% in control genotype mice did not interfere 
with the ability of vessel reassembly to prevent neovascular 
lesion formation 5 days after return to room air (Figure 6, E–G). In 
contrast, vessel reassembly in Bak–/– BaxEC/EC mice was effective at 
reducing neovascular area by 88% (Figure 6G).
The mature retinal vasculature consists of 3 layers: superficial, 
middle, and deep. Bak–/– BaxEC/EC mice had established more exten-
sive vessel networks in these layers than control mice 5 days after 
return to room air, evident from the extent of vaso-obliterated 
area repair (Figure 6, F and H) and the vessel area in these layers 
(Supplemental Figure 5, F–H). None of this was affected when 
VEGFA was neutralized in mice of either genotype (Figure 6H and 
Supplemental Figure 5, F–H). Taken together, these data show that 
vessel reassembly in the absence of EC apoptosis is not dependent 
on abnormally high VEGFA levels or impeded when VEGFA levels 
are reduced to a level sufficient to suppress aberrant neovascular-
ization or ESM1 expression.
Reducing ANG2 does not prevent vessel reassembly, but does 
impair angiogenic expansion of reassembled vessels. Our data show 
that vessel reassembly occurs in response to hypoxia by cells 
that exhibit hallmark features of endothelial tip cells. ANG2 is 
Figure 3. Isolated ECs protected from apoptosis rapidly reassemble to 
revascularize hypoxic retinas. (A and B) PECAM1 staining of control and 
Bak–/– BaxEC/EC retinas exposed to high oxygen for 48 hours followed by 24 
hours in room air (48 + 24 RA). Scale bars: 500 μm (A); 60 μm (B). Arrows 
indicate sprouting vessels. Boxed areas are enlarged in B (top, yellow box; 
bottom, pink box). (C) Vessel area in 48 + 24 RA control (n = 11) and Bak–/– 
BaxEC/EC (n = 12) central retinas. Data for normoxic mice or mice exposed to 
high oxygen for 48 hours from Figure 1D are included for comparison. Two-
way ANOVA using Tukey’s multiple-comparisons test. (D) Central retinal 
vasculature from control and Bak–/– BaxEC/EC mice exposed to 48 hours of high 
oxygen or 48 + 24 RA stained for collagen IV (red) and PECAM1 (cyan). Scale 
bars: 80 μm. (E and F) Network fragmentation (n = 10) and vessel regression 
(n = 4) in 48 + 24 RA Bak–/– BaxEC/EC central retinas. Data for normoxic mice or 
mice exposed to 48 hours of high oxygen from Figure 1, F and G, are included 
for comparison. One-way ANOVA with Tukey’s multiple-comparisons test. 
Quantitative data from control mice exposed to high oxygen are not shown 
because there are no central retina capillaries remaining. (G) Static images 
from live-imaging retinal explants showing vessels reassembling starting 
12 hours after return to room air following 48 hours of exposure to high 
oxygen. Four independent clusters are shown. Time stamp is hh:mm (time 
0 = 12 hours after return to room air). Arrows indicate where sprouts form 
new connections. Scale bars: 50 μm. (H) Sprouting clusters from a 48 + 12 RA 
Bak–/– BaxEC/EC retina. Scale bar: 50 μm. Arrows indicate filopodial projections. 
All data are mean ± SEM. Each circle represents 1 animal.
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fragmentation and reassembly and treated with either an ANG2-
neutralizing antibody (63) or an isotype control antibody on return 
to room air (Figure 7C). No difference was observed in the central 
retina vessel area or network fragmentation between treatment 
groups in the Bak–/– BaxEC/EC mice, suggesting that ANG2 inhibition 
did not inhibit vessel reassembly (Figure 7, D–F). ANG2 inhibition 
did, however, reduce endothelial tip cell activity in the retina. 
WT mice treated with ANG2-neutralizing antibody following 
return to room air showed a 65% reduction in tip cells based on 
the morphological criteria of filopodial clusters (Supplemental 
Figure 6, B and C), consistent with the known role of ANG2 in 
promoting tip cell activity in the retina (53). Consistent with this, 
ANG2 inhibition prevented the formation of new vessel networks 
from the reassembled vessels by sprouting angiogenesis. Whereas 
extensive superficial- and mid-layer vasculature was present in 
ANG2-inhibited Bak–/– BaxEC/EC retinas 5 days after return to room 
air as a result of vessel reassembly (Figure 7, G and H), these 
animals contained less deep-layer vasculature compared with 
isotype control–treated mice (Figure 7, G–I). Deep-layer vessels 
form from vessel sprouts that emerge from the superficial layer. 
highly expressed in tip cells (52–54) and is essential for sprouting 
angiogenesis in the retina (53, 55, 56). ANG2 is upregulated in ECs 
by hypoxia (57–60), including in the OIR model (57). Given this, 
we sought to determine whether ANG2 was necessary for vessel 
reassembly. To investigate ANG2 expression in reassembling 
vessels, control and Bak–/– BaxEC/EC mice were exposed to high 
oxygen for 48 hours, returned to room air for 12 or 24 hours, 
and then stained for ANG2. As expected, ANG2 expression in 
control mice was strongly upregulated in ECs along the sprout 
front adjacent to the avascular central retina at both time points 
(Figure 7A). As previously reported for this antibody (61, 62), 
ANG2 was expressed preferentially in ECs located at the sprout 
front, consistent with tip cell identity (Supplemental Figure 6A). 
In Bak–/– BaxEC/EC mice we found strong ANG2 expression in the 
reassembling endothelium in the central retina 12 hours after 
return to room air (Figure 7B). By 24 hours, when most reassembly 
was complete, only a few patches of ECs with strong ANG2 
expression remained (Figure 7B, yellow arrows).
To test whether ANG2 was necessary for vessel reassembly, 
Bak–/– BaxEC/EC mice were exposed to 48 + 24 RA to induce network 
Figure 4. Vessel reassembly in Bak–/– BaxEC/EC retinas 
uses preexisting, apoptosis-protected ECs. (A) EC 
proliferation in 48 + 24 RA control and Bak–/– BaxEC/EC 
retinas visualized by staining for phospho–histone H3 
(Ser10) (cyan) and PECAM1 (red). Dashed lines demarcate 
boundary between peripheral and central retina. Scale 
bars: 200 μm. (B) Quantification of proliferating ECs 
within central retina of 48 + 24 RA control (n = 3) and 
Bak–/– BaxEC/EC (n = 3) mice. Student’s 2-tailed t test. (C 
and D) Representative images and quantification of EC 
number in Bak–/– BaxEC/EC central retina vessels from nor-
moxic mice (n = 3) or mice exposed to 48 hours of high 
oxygen alone (n = 3) or with 24 hours of recovery in room 
air (48 + 24 RA) (n = 3). EC number is quantified based 
on EC nuclei (costaining of FLI1 or ERG with EC marker 
PECAM1 or isolectin B4). Quantitative data from control 
mice are not shown because there are no central retina 
capillaries remaining following exposure to high oxygen. 
Scale bars: 20 μm. One-way ANOVA. All data are mean ± 
SEM. Each circle represents 1 animal.
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basement membranes left behind during vessel regression can 
act as a scaffold for vessel regrowth (66, 67). It is likely that this 
was occurring during vessel reassembly, as the PECAM1/collagen 
IV ratio returned to normal during vessel reassembly, suggesting 
that it involves, at least to some extent, recanalization of empty 
basement membranes.
Unlike normal sprouting angiogenesis, in which EC 
proliferation is coupled to new-vessel growth (47), the sprouting 
and network reassembly we observed in the absence of apoptosis 
proceeded largely without the need for EC proliferation. While 
the exact reasons for this lack of proliferation are unclear, the 
unchanging number of ECs throughout the process of network 
fragmentation and reassembly possibly suggests some form of 
negative feedback mechanism on proliferation. Additionally, 
many of the reassembling ECs showed morphological and 
molecular features consistent with tip cell activity/identity, a state 
known to have less proliferative activity than other EC types (64). 
Nonetheless, the formation of extensive deeper-layer vasculature 
suggests that reassembled vessels retain the capacity for further 
network growth that likely does require EC proliferation. Deep-
layer retinal vessels grow from vessel sprouts originating from the 
superficial vascular layer and have not yet formed when mice start 
the OIR procedure. These vessels therefore do not reassemble 
from existing EC clusters in the apoptosis-resistant mutants in the 
same way the superficial layer does. The presence of deep-layer 
vasculature in Bak–/– BaxEC/EC mice 5 days after return to room air 
therefore suggests that reassembled superficial layer vessels are 
competent to undergo further sprouting angiogenesis to give rise 
to the new vessel networks in the deeper layers. These vessels are 
important for normal retina function, as defects in their formation 
are associated with diseases that cause vision loss (68).
Vessel reassembly occurred in response to hypoxia, prompting 
us to investigate whether it was dependent on the hypoxia-induced, 
proangiogenic growth factors VEGFA and ANG2. Both VEGFA and 
ANG2 are upregulated in the OIR model following the onset of 
hypoxia (36, 48, 57) and are required for pathological neovascular 
lesion formation (44, 45, 49, 69). Our data show that reducing 
VEGFA to levels that suppress pathological angiogenesis did not 
interfere with the vessel reassembly that occurs in the absence of 
EC apoptosis. While these findings do not necessarily exclude a role 
for low-level VEGFA in the reassembly process, they do show that 
it can proceed at levels of VEGFA that are limiting for pathological 
angiogenesis, or reduce ESM1 expression by 94%. While the 
effects of VEGFA-neutralizing antibodies on neovascularization 
and ESM1 expression that we observe suggest direct inhibition 
in the retina based on other experimental evidence (44, 45, 49, 
51), we cannot rule out systemic effects following intraperitoneal 
administration of the neutralizing antibodies.
ANG2 is a proangiogenic growth factor expressed in endothelial 
tip cells (52–54). It is essential for sprouting angiogenesis in the 
retina (53, 55, 56). Despite the fact that ANG2 was upregulated 
in the ECs of reassembling vessels, neutralization of ANG2 did 
not prevent vessel reassembly. ANG2 was, however, required for 
reassembled vessels to undergo subsequent angiogenic expansion 
to form deep-layer vasculature. The requirement for ANG2 in the 
formation of deep-layer vessels has been previously demonstrated 
in the context of normal, developmental retinal angiogenesis (55, 
We observed strong ANG2 expression in these sprouts in the 
periphery of Bak–/– BaxEC/EC retinas 24 hours after return to room 
air (Figure 7B, pink arrows), and formation of these vessels during 
normal retinal development is impaired in Ang2 mutants (55, 56). 
Taken together, these data suggest that ANG2 is not required for 
the initial process of vessel reassembly, but is required for further 
expansion of the reassembled vessels by sprouting angiogenesis.
Discussion
While blocking apoptosis has previously been shown to prevent 
neovascularization in the OIR model (23), the way it did so was 
unknown. We show that protecting against BAK/BAX-dependent 
apoptosis did not prevent the initial loss of perfusion or breakdown 
of the vasculature through vessel regression that leads to areas of 
the retina becoming ischemic. Rather, it allowed those ECs that 
would ordinarily die during the process of vessel regression to 
survive and persist. These did not persist as intact or functional 
vessels, but instead as isolated clusters of cells scattered throughout 
the ischemic zones. As the tissue surrounding these isolated ECs 
became hypoxic, they underwent a sprouting angiogenic response. 
Through this, they reestablished connections with each other 
and neighboring vessels, reassembling into a functional network. 
These reassembled vessels rapidly restored oxygen supply to the 
ischemic tissue, thereby diminishing hypoxia-induced pathological 
responses (Supplemental Figure 6D). Our data show that this 
mechanism replaces vessels sooner than normal angiogenesis 
would, which must grow a new network (including replacement 
ECs lost to apoptosis during vaso-obliteration) from vessels 
peripheral to the ischemic lesion (Supplemental Figure 6D).
We found that ischemia in the OIR model was caused by 
EC apoptosis–independent vessel closure, predominantly in 
arterial side-branch vessels. Vessel closure in the OIR model 
has been shown to depend on DLL4/Notch signaling through 
the regulation of vasoactive gene expression (41). Arterial side-
branch closure led to the loss of blood flow to downstream 
capillaries, suggesting that loss of blood flow shear constitutes 
the major initiating event in vaso-obliteration. Previous studies 
have suggested that vessel closure occurs before apoptosis (41, 
42). When apoptosis was blocked, capillaries deprived of blood 
flow still initiated a vessel regression response in which vessels 
disassembled and ECs retracted into isolated clusters resulting in 
network fragmentation. The vessel regression seen in the absence 
of apoptosis likely involves a process of cell migration similar 
to that which occurs in normal angiogenic vessel pruning. That 
process also occurs in response to blood flow changes (25–28) and 
is independent of EC apoptosis (24).
When protected from apoptosis, ECs in the fragmented, 
nonperfused vessels retained the capacity to initiate a sprouting 
angiogenesis phenotype. This occurred in response to hypoxia. 
These cells displayed behavioral and morphological features 
typical of endothelial tip cells that guide the growth of new vessels 
during sprouting angiogenesis (64). This process is responsible 
for the vascularization of the retina in response to physiologic 
hypoxia (1, 65). Through this behavior, the isolated cells were 
able to reestablish connections with neighboring vessels and 
reassemble into a functional network. In some instances, ECs 
appeared to migrate along predetermined paths. Empty vascular 
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stimuli to reassemble themselves into a functional vessel network, 
resulting in rapid network repair and tissue reoxygenation. 
This had the effect of reducing hypoxia, pathological 
neovascularization, and reactive retinal gliosis. Manipulation of 
other pathways, such as ANG1 (44) and ATM signaling (75), has 
also been shown to accelerate the repair of the retinal network 
and reduce neovascularization in the OIR model. In these cases, 
vaso-obliteration proceeded normally, and enhanced centripetal 
growth of the peripheral vascular network accounted for the vessel 
repair and took longer than the reassembly process we describe 
(44, 75). Blocking apoptosis in the OIR model therefore enabled 
a fundamentally different and faster approach for restoring blood 
supply to the ischemic retina.
Network reassembly became less efficient the longer ECs 
were exposed to high oxygen and therefore in the fragmented, 
flow-deprived state. While this reduced efficiency may simply 
reflect the fact that more fragmentation had occurred at these later 
time points, taking longer to repair, other factors may contribute 
to hinder the process. By 48 hours, ECs had downregulated the 
transcription factor FLI1 and may downregulate other genes 
that may affect their responsiveness to angiogenic stimuli. 
Changes to the neurovascular unit over time likely also affect 
reassembly. Astrocytes promote retinal angiogenesis both in 
normal development (37) and in vessel regrowth in the OIR model 
(44, 76). The astrocyte network deteriorates rapidly beyond 24 
hours of exposure to high oxygen (77). This may explain why 
revascularization in our model was less efficient, but still effective, 
beyond 24 hours of high oxygen exposure.
Current treatments for neovascular disease in the retina 
revolve around reducing the angiogenic stimulus. This is done 
either by decreasing the metabolic demand of the retina or by 
directly inhibiting VEGFA (8–12). Our findings show that in 
the OIR model for retinopathy of prematurity, preventing EC 
apoptosis can accelerate revascularization of the retina and reduce 
the hypoxic stimulus that drives abnormal VEGFA expression. 
Our data show that protecting ECs from apoptosis in this model 
enables them to persist within ischemic tissue without the need 
for ongoing blood flow support and reestablish functional vessels 
sooner than normal angiogenic growth can achieve. Furthermore, 
like VEGFA inhibition, blocking apoptosis in the OIR model was 
effective at preventing subsequent neovascular response. These 
findings may also have implications for restoring blood flow in 
other ischemic retinopathies and diseases such as stroke and 
myocardial infarction.
Methods
Mice. Conditional Bax mice (78), Bak-null mice (79), Tie2-Cre mice 
(80), Cdh5(PAC)-CreERT2 mice (32), caspase-8–null mice (81), Mlkl-
null mice (82), and ROSA26Sortm4(ACTB-tdTomato,-EGFP)Luo (mTmG) mice (46) 
have been previously described. Conditional Vegfr2 mice crossed 
with Tie2-CreERT2 have been described previously (39) and show 
80% reduction of endothelial VEGFR2 protein along with loss of ECs 
from nonretinal organs following tamoxifen administration (39, 83). 
Animals were maintained on an inbred C57BL/6 background. The day 
of birth was termed P0. Mice of both sexes were used. Bak–/– BaxiEC/iEC 
mice were injected with 50 μg tamoxifen (MP Biomedicals; dissolved 
in sterile corn oil plus 5% ethanol) by intragastric injection at P2 and 
56). While we cannot rule out the possibility that some level of 
ANG2 activity is required for vessel reassembly, our results suggest 
that the threshold is lower than that needed for normal sprouting 
angiogenesis. While the effects of ANG2 neutralization on tip cell 
activity, sprouting angiogenesis, and deep-layer vessel formation 
match previous genetic and inhibitor-based studies in vivo (53, 
55, 56) and in vitro (70, 71) and suggest direct neutralization of 
ANG2 in the retina, we cannot rule out systemic effects following 
intraperitoneal administration of the neutralizing antibodies. We 
also cannot rule out the possibility that vessel reassembly occurs 
before the full effect of ANG2- or VEGFA-neutralizing antibodies 
manifests. However, vessel reassembly became less efficient 
following longer exposure to high oxygen, and VEGFA and ANG2 
neutralization still did not prevent reassembly even following 
longer (3 days) exposure to high oxygen.
Sprouting angiogenesis and tip cell activity are regulated by 
many signaling inputs in addition to VEGFA and ANG2. These 
include BMPs, FGFs, Notch, cell adhesion, and direct hypoxia 
sensing, among others (72), any of which may be essential 
during the vessel reassembly process. In addition to forming new 
vessel sprouts indicative of tip cell activity, vessel reassembly 
also appeared to involve recanalization of preexisting basement 
membranes. This process may not be as dependent on factors 
involved in normal sprouting angiogenesis and may point to the 
requirement of other pathways, the identity of which will require 
further investigation.
The reassembly of vessel fragments we observed bears 
similarities to vessel formation in other contexts. During 
vasculogenesis, angioblasts coalesce into endothelial cords before 
establishing lumenized vessels (2); isolated clusters of lymphatic 
ECs incorporate into growing lymphatic vessel networks (73); and 
isolated vessel segments in the rat mesentery reconnect during 
network growth (74). We showed that isolated ECs protected 
from apoptosis driven by BAK and BAX can respond to hypoxic 
Figure 5. Reassembled vessels in Bak–/– BaxEC/EC retinas are functional 
and limit neovascularization and retinal injury. (A) 48 + 24 RA con-
trol and Bak–/– BaxEC/EC retinas perfused i.v. with lectin and stained for 
PECAM1. (B) Hypoxia visualized by pimonidazole (red) staining (costained 
with PECAM1, cyan) in control and Bak–/– BaxEC/EC retinas exposed to high 
oxygen for 48 hours followed by 24 hours in room air (48 + 24 RA). Scale 
bars: 500 μm. (C) Central retina hypoxia in P8 normoxic mice (control, 
n = 3; Bak–/– BaxEC/EC, n = 3) following 48 hours in high oxygen (control, 
n = 6; Bak–/– BaxEC/EC, n = 5) or 48 + 24 RA (control, n = 6; Bak–/– BaxEC/EC, 
n = 4). Two-way ANOVA using Tukey’s multiple-comparisons test. (D) 
Quantification of VEGFA protein in whole retina extracts from 48 + 24 RA 
control (n = 4) and Bak–/– BaxEC/EC (n = 4) mice and age-matched normoxic 
controls (control, n = 4; Bak–/– BaxEC/EC, n = 4). Two-way ANOVA using 
Tukey’s multiple-comparisons test. (E) Experimental overview of OIR 
procedure used in F–J. (F–H) Representative examples and quantification 
of neovascular area in P15 control (n = 8) and Bak–/– BaxEC/EC (n = 5) retinas 
stained for collagen IV and PECAM1. Yellow lines outline neovascular 
lesions (F); arrowheads indicate glomerular-like lesions (G). Scale bars: 
500 μm (F); 50 μm (G). Student’s 2-tailed t test. (I and J) Representative 
images and quantification of Müller cell gliosis visualized by GFAP (gray) 
staining comparing mice subjected to OIR (control, n = 6; Bak–/– BaxEC/EC, n 
= 6) and age-matched controls raised in room air (normoxia; control, n = 
2; Bak–/– BaxEC/EC, n = 2). Isolectin B4 labels ECs (magenta). Scale bars: 100 
μm. Two-way ANOVA with Tukey’s multiple-comparisons test. All data are 
mean ± SEM. Each circle represents 1 animal.
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Figure 6. Vessel reassembly is insensitive to VEGFA neutralization. (A) Experimental overview of mice analyzed in B–D. (B and C) Representative 
images and quantification of central retinal vasculature in mice subjected to the time course shown in A and treated with isotype control (control, n = 4; 
Bak–/– BaxEC/EC, n = 8) or anti-VEGFA (control, n = 3; Bak–/– BaxEC/EC, n = 8). Stained for PECAM1. Scale bars: 500 μm. Two-way ANOVA with Tukey’s multi-
ple-comparisons test. (D) Quantification of central retina hypoxic area in Bak–/– BaxEC/EC mice subjected to the time course shown in A and treated with 
isotype control (n = 3) or anti-VEGFA (n = 3). Student’s 2-tailed t test. (E) Experimental overview of mice analyzed in F–H. (F) Representative examples 
of neovascularization (yellow outline) in control and Bak–/– BaxEC/EC retinas treated with anti-VEGFA or isotype control antibodies. Scale bars: 500 μm. (G) 
Quantification of neovascular area in retinas from control (isotype, n = 5; anti-VEGFA, n = 4) and Bak–/– BaxEC/EC mice (isotype, n = 6; anti-VEGFA, n = 7). 
Two-way ANOVA with Tukey’s multiple-comparisons test. (H) Quantification of vaso-obliterated area in retinas from control (isotype, n = 5; anti-VEGFA, 
n = 4) and Bak–/– BaxEC/EC mice (isotype, n = 6; anti-VEGFA, n = 7). Two-way ANOVA with Tukey’s multiple-comparisons test. All data are mean ± SEM. Each 
circle represents 1 animal.
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Pimonidazole was detected using rabbit anti-pimonidazole antibody 
and staining performed as above. For i.v. lectin perfusion, P7 pups 
were anesthetized using Xylazil-20 (20 mg/kg; Troy Laboratories 
Pty. Ltd.) and ketamine (100 mg/kg; Hospira Australia Pty. Ltd.) 
via i.p. injection; then 30 μL of DyLight488-conjugated Lycopersicon 
esculentum lectin (Vector Laboratories, DL-1174) was injected retro-
orbitally and allowed to circulate for 2 minutes before retinas were 
fixed, dissected, and stained as above. In mice subjected to 48 + 24 RA, 
L. esculentum lectin was injected intracardially, via the left ventricle. 
For cryosectioning, P18 retinas were fixed for 24 hours, equilibrated 
in 30% sucrose in DPBS for at least 1 hour at room temperature, and 
frozen in OCT embedding compound (Scigen). Twenty-micrometer 
cryosections were adhered to Polysine slides (Thermo Scientific), 
washed in DPBS, then blocked and stained as for whole-mount retinas.
Imaging and image analysis. Retinas were imaged with a Leica TCS 
SP8 confocal microscope using ×10/0.4 NA, ×20/0.75 NA, or ×40/1.30 
NA objectives and Leica Application Suite software. All image analysis 
was performed in the Fiji distribution of ImageJ software (NIH) (84). 
Apoptotic ECs (defined as cleaved [active] caspase-3+/PECAM1+ 
cells enclosed by collagen IV signal) were quantified manually from 
confocal Z-stack images from the central retina at P8 and normalized 
to central retina area. Central retina vessel area was calculated based 
on PECAM1 signal from maximum-intensity projection images 
following application of a median filter (2 pixels) and a “despeckle” 
filter before manual adjustment of threshold and measurement of 
area. Vessel area was normalized to total area of the central retina. 
Vessel regression was determined from equivalent areas as a ratio of 
PECAM1+ vessel segment length to collagen IV+ vessel segment length 
in a semiautomated fashion. Binary masks of both PECAM1 and 
collagen IV channel were made manually by various morphological 
filters and thresholding signal. Collagen IV+ PECAM1– vessel segment 
mask (i.e., regressing vessels) was generated by subtraction of 
PECAM1 mask from collagen IV mask. Collagen IV+ PECAM1– mask 
and collagen IV mask were then skeletonized, and length of vessels 
within each mask was measured. Collagen IV+ PECAM1–/collagen 
IV ratio was generated automatically based on vessel length. Data 
are represented as PECAM1/collagen IV ratio. ICAM2/collagen IV 
ratio was calculated in the same way, replacing PECAM1 with ICAM2 
signal. Arterial side branches were counted as perfused if lectin signal 
overlapped continuously with ICAM2. Number of perfused arterial 
side branches within the central retina was counted and normalized 
to artery length. Nonperfused side branches were further categorized 
as “attached,” “disrupted,” or “detached” based on ICAM2 signal. 
“Attached” vessels were not perfused but had normal ICAM2 signal 
(identical appearance to perfused side branches). “Disrupted” side 
branches had abnormal ICAM2 morphology compared with normal 
vessels, suggesting they were in the process of closing their lumen 
and detaching from the artery. “Detached” side branches did not have 
continuous ICAM2 signal between side branch and major artery but 
did have continuous collagen IV signal. EC number was counted within 
equivalent regions of the same size and normalized to retina area. EC 
nuclei were counted manually based on ERG or FLI1 nuclei in cells 
positive for vascular markers (isolectin B4 or PECAM1). Number of 
FLI1 particles (nuclei) was counted after application of a median filter 
(2 pixels), removal of noise with “despeckle” function, and analysis of 
particles greater than 20 square pixels. Particles were then manually 
checked through confocal Z-stacks to ensure all ECs were counted. EC 
P3. For conditional Vegfr2 mice, tamoxifen (MilliporeSigma) was 
dissolved in ethanol and diluted in sterile corn oil to 1 μg/μL, mice 
were injected i.p. with 50 μg at P7, P8, and P9, and eyes were dissected 
for analysis at P10. Control genotypes for experiments involving Bak–/– 
BaxEC/EC and Bak–/– BaxiEC/iEC mice were Bak–/– Baxfl/+ Cre+, Bak–/– Baxfl/+ 
Cre–, and Bak–/– Baxfl/fl Cre–.
Oxygen-induced retinopathy. Nursing dams with P7 pups were 
housed in a Perspex chamber (BioSpherix) and exposed continuously 
to 74% ± 1% oxygen in air maintained by a ProOx110 oxygen controller 
(BioSpherix). Duration of oxygen exposure and subsequent recovery 
time in room air is indicated in each figure. Pups were fostered to 
BALB/c females following exposure to 3 days of high oxygen to prevent 
oxygen toxicity in dams.
VEGFA and ANG2 neutralization experiments. Mouse anti–mouse/
human VEGFA neutralizing antibody B20-4.1.1 (50) (Genentech) and 
control mouse anti–human CD8a antibody OKT8 (WEHI Antibody 
Facility) were administered to mice by i.p. injection at the time points 
indicated either at 5 mg/kg or at the dose stated in the figure legend. 
Human anti–mouse/human ANG2 antibody ABA (63) (provided by 
Gou Young Koh, KAIST, Daejeon, South Korea) and control human 
anti–respiratory syncytial virus antibody palivizumab (provided by 
Steven A. Stacker, Peter MacCallum Cancer Centre, Melbourne, Vic-
toria, Australia) were administered to mice by i.p. injection at 20 mg/
kg at the time points indicated.
Immunohistochemical staining. For whole-mount immunohisto-
chemistry, eyes were fixed for 2 hours in 4% paraformaldehyde at 
4°C before dissection and blocking of retinas for 1 hour at room 
temperature in Dulbecco’s phosphate-buffered saline (DPBS) with 
1% Triton X-100 and 2% donkey or goat serum. Retinas were stained 
with primary antibodies prepared in blocking solution overnight at 
4°C, washed in DPBS containing 0.01% Triton X-100, then stained 
overnight with secondary antibodies prepared in blocking solution. 
Primary antibodies were rat anti-PECAM1/CD31 (BD Pharmingen, 
553370, clone MEC13.3), goat anti-PECAM1/CD31 (R&D Systems, 
AF3628), goat anti–collagen IV (Merck, AB769), rabbit anti–cleaved 
(active) caspase-3 (Cell Signaling, 9664, clone 5AE1), rat anti-ICAM2/
CD102 [BD Pharmingen, 553326, clone 3C4(mIC2/4)], rat anti–
VE cadherin (BD Pharmingen, 555289, clone 11D4.1), rabbit anti-
pimonidazole (Hypoxyprobe, PAb2627AP), rabbit anti-NG2 (Merck, 
AB5320), rabbit anti-ERG (Abcam, ab110639, clone EPR3863), rabbit 
anti-FLI1 (Abcam, ab15289), rabbit anti-GFAP (DAKO, Z0334), 
human anti-ANG2 (4H10) (63), rabbit anti–phospho–histone H3 
(Ser10) conjugated to AF488 (Merck, 06-570-AF488), and goat 
anti-ESM1 (R&D Systems, AF1999). Secondary antibodies were 
donkey anti-rabbit–Cy3 (711-165-152), donkey anti-rabbit–AF647 
(711-605-152), donkey anti-rat–DL488 (712-485-153), donkey anti-
rat–Cy3 (712-165-150), donkey anti-rat–AF647 (712-605-150), 
donkey anti-goat–DL405 (705-475-147), donkey anti-goat–Cy3 
(705-165-147), and streptavidin-AF488 (016-540-084) (all from 
Jackson ImmunoResearch Laboratories). For isolectin B4 (Vector 
Laboratories, B-1205) staining, retinas were blocked in 1% BSA, 0.3% 
Triton X-100 in DPBS, then incubated with isolectin B4 in 0.4% 
Triton X-100 in HBSS. Retinas were mounted with Prolong Diamond 
(Invitrogen, P36961). For hypoxia detection, pups were injected i.p. 
with 60 mg/kg pimonidazole (Hypoxyprobe) either immediately 
after exiting the oxygen chamber (30 minutes labeling duration) 
or 24 hours after exiting the chamber (2 hours labeling duration). 
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Retinas were live-imaged with an inverted Leica SP8 confocal micro-
scope using a HyD detector and a ×10/0.4 NA objective. Retinas were 
maintained at 37°C and 5% humidified CO2. Images were acquired 
every 30 minutes for 5 hours. After acquisition, a mean filter (1 pixel) 
was applied to the images using Fiji software.
VEGFA ELISA. VEGFA levels in whole retina lysates were 
quantified using a mouse VEGF Quantikine ELISA kit (R&D Systems, 
MMV00) per the manufacturer’s instructions. Briefly, freshly 
dissected whole retinas were snap-frozen in dry ice, thawed in 50 μL 
of DPBS, and homogenized by manual trituration 20 times. Retina 
homogenates were subject to 2 freeze/thaw cycles, then centrifuged at 
5000 g for 5 minutes. An equal volume of lysate was then assayed per 
retina. VEGFA concentrations were calculated from a standard curve 
generated by 4-parameter logistic regression analysis in R version 
3.4.4 using the drc package (86).
Statistics. All data are shown as mean ± SEM. Statistical analyses 
were performed for all quantitative data using Prism 7.0 (GraphPad) 
or in R version 3.4.4 where specified. P values below 0.05 were con-
sidered significant.
Study approval. All experiments involving animals were per-
formed with procedures approved by The Walter and Eliza Hall Insti-
tute of Medical Research Animal Ethics Committee or with University 
of Nottingham Animal Welfare and Ethical Review Board approval.
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proliferation was determined by manual counting of phospho–histone 
H3 (Ser10)+ FLI1+ nuclei and normalized to total EC number in each 
region of the retina. ECs were then assigned as peripheral or central 
region based on demarcation described above. Network fragmentation, 
vessel branch points, and vessel width were quantified from PECAM1 
images of central retina vasculature. A median filter (2 pixels) was first 
applied to the PECAM1 images, which were then segmented using 
the Trainable Weka Segmentation Plugin in Fiji (85). Segmented 
images were then skeletonized. The number of separate, independent 
network skeletons was used as a measure of network fragmentation. 
The number of skeletons and the number of vessel branch points were 
both normalized to central retina area. Vessel width was calculated as 
total vessel area divided by total vessel length calculated from Weka-
segmented images. Hypoxic area in the central retina was quantified 
from pimonidazole images. A 20-pixel median filter was applied to 
the images and a signal intensity threshold used to distinguish hypoxic 
signal from background. Hypoxic area was normalized to total central 
retina area. Neovascular tufts were quantified based on maximum-
intensity projection images of collagen IV signals, with neovascular 
lesions defined as bright, globular collagen IV+ structures. These 
were segmented manually in Adobe Photoshop CC 2015 and the area 
calculated in Fiji. Neovascular area per retina was normalized to total 
retina area. Where necessary, a despeckle filter was applied to select 
channels in images displayed in figures for clarity.
Retina live imaging. Bak–/– BaxiEC/iEC mTmG mice were injected with 
tamoxifen as described above by intragastric injection at P2 and P3. 
Dam and pups were exposed to high oxygen for 48 hours followed 
by 12 hours in room air. Retinas were then dissected immediately 
in cold DMEM, and 5 radial incisions were made; then retinas were 
flat-mounted with the internal limiting membrane face-down on a 
disc of 1% low-melting-point agarose gel dissolved in DMEM contain-
ing 10% FCS, and set in a 35-mm culture dish with coverglass bottom 
(Eppendorf, 0030740017). Nitex 50-μm filter mesh (Sefar, 03-50/31) 
dipped in molten 1% agarose/DMEM/10% FCS mixture was laid on 
top of the retina and allowed to set briefly to minimize retina move-
ment during imaging. The dish was then fixed into a custom 3D 
printed stage insert with inbuilt water reservoirs to maintain humidity. 
Figure 7. ANG2 is not required for vessel reassembly but is required for 
expansion of reassembled network. (A and B) Representative images 
of ANG2 (magenta, gray) expression in control and Bak–/– BaxEC/EC retinas 
exposed to high oxygen for 48 hours followed by return to room air for 12 
hours (+ 12 RA) or 24 hours (+ 24 RA). Costained with PECAM1 (cyan). Pink 
arrows indicate ANG2+ downward sprouts; yellow arrows indicate patches 
of ANG2+ vessels. Scale bars: 100 μm. (C) Experimental overview of mice 
analyzed in D–F. (D and E) Representative images and quantification of 
central retinal vasculature in Bak–/– BaxEC/EC mice subjected to the time 
course shown in C and treated with isotype control (n = 3) or anti-ANG2 
(n = 4). Stained for PECAM1. Scale bars: 500 μm. Student’s 2-tailed t test. 
(F) Quantification of network fragmentation in the central retina of Bak–/– 
BaxEC/EC mice subjected to the time course shown in C and treated with 
isotype control (n = 3) or anti-ANG2 (n = 4). Data for Bak–/– BaxEC/EC  
mice exposed to 48 hours of high oxygen from Figure 1G are shown for 
comparison. Student’s 2-tailed t test. (G–I) Representative images and 
quantification of vascular area in separate layers from the same field of 
view of the central retinas of control (isotype control, n = 3; anti-ANG2,  
n = 4) and Bak–/– BaxEC/EC mice (isotype control, n = 4; anti-ANG2, n = 4). 
Scale bars: 100 μm. Two-way ANOVA with Tukey’s multiple-comparisons 
test. All data are mean ± SEM. Each circle represents 1 animal.
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